Auben Residential Growth Fund Series 1, LLC (CIK: 0002049381) EDGAR, Information, Filings... CompaniesBIO.Com

Auben Residential Growth Fund Series 1, LLC

Mailing address
909 WALKER STREET, AUGUSTA, Georgia, 30901
Phone
706-627-0975
State location
Georgia
State of incorporation
Georgia
Fiscal year end
December 31
SIC
N/A
Filings
N/A

Auben Residential Growth Fund Series 1, LLC (CIK: 0002049381) is an American company incorporated in the state of Georgia. Head office is located at 909 WALKER STREET, AUGUSTA, Georgia, 30901. Work in the industry N/A. Auben Residential Growth Fund Series 1, LLC is a public company and trade via Over-The-Counter (OTC).

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Auben Residential Growth Fund Series 1, LLC

Filings	Format	Description	Filed/Effective	File/Film Number
D	Document	Acc-no: 0002049381-24-000001 (33 Act) Size: KB	Dec-19-2024	021-532720 241562213

Recent 20 filings. View all Auben Residential Growth Fund Series 1, LLC filings

Overall rating 5.0

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Auben Residential Growth Fund Series 1, LLC overview
Auben Residential Growth Fund Series 1, LLC job
Auben Residential Growth Fund Series 1, LLC stock
Auben Residential Growth Fund Series 1, LLC ownership
Auben Residential Growth Fund Series 1, LLC CEO
Auben Residential Growth Fund Series 1, LLC documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.